Literature DB >> 17447391

A placebo controlled double blind clinical trial of mitomycin C in primary trabeculectomy in Ethiopian patients.

Taffessework Girma, Paul Courtright, Fekede Mengistu, Tinebeb Tamirat, Zemene Birhanu.   

Abstract

OBJECTIVE: To determine if surgery with mitomycin has an increased success rate in reducing introccular pressure after trabeculectomy in Ethiopian patients
METHODS: A double blind clinical trial using mitomycin C and placebo during primary trabeculectomy was carried out on 31 patients and 31 controls. 31 patients and 28 controls completed the study period Post operative intra ocular pressure and post operative complications were assessed
RESULTS: There was no statistically significant difference in the postoperative intra ocular pressure in both groups (p = 0.6 95% CI). However there was a statistically significant higher rate of complications in the cases when compared to the controls (p = .002 95% CI).
CONCLUSION: A controlled study with adequate power using different dosages of mitomycin is recommend

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17447391

Source DB:  PubMed          Journal:  Ethiop Med J        ISSN: 0014-1755


  3 in total

1.  Is Beta Radiation Better than 5 Flurouracil as an Adjunct for Trabeculectomy Surgery When Combined with Cataract Surgery? A Randomised Controlled Trial.

Authors:  Kazim Dhalla; Simon Cousens; Richard Bowman; Mark Wood; Ian Murdoch
Journal:  PLoS One       Date:  2016-09-08       Impact factor: 3.240

2.  No effects of mitomycin-C in primary trabeculectomies in Sweden.

Authors:  Marcelo Ayala
Journal:  SAGE Open Med       Date:  2018-06-18

3.  Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency.

Authors:  Sadhana V Kulkarni; Karim F Damji; Yvonne M Buys
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.